Actively Recruiting
Evaluation of the Safety and Effectiveness of the Calibreye Glaucoma Implant in Adults with Open-Angle Glaucoma
Led by Myra Vision Inc. · Updated on 2025-12-15
60
Participants Needed
4
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety and feasibility of the Calibreye System, a glaucoma device, in patients with open-angle glaucoma. The study focuses on a surgical procedure using this implant to reduce intraocular pressure, which is important for managing this eye condition. It is a prospective, nonrandomized, open-label feasibility clinical trial sponsored by Myra Vision Inc. Participants will receive the Calibreye glaucoma device as a permanent implant. The study does not include a comparison group and will monitor the effects of the device implantation over time. The focus is on how well the device works to lower intraocular pressure and its safety during and after surgery. During the study, participants will be assessed for intraocular pressure and any adverse events for up to 12 months. Researchers will also track the use of glaucoma medications over this period. The study involves monitoring safety and effectiveness through clinical visits and evaluations, lasting up to one year from device implantation.
CONDITIONS
Brief Title
Feasibility Clinical Evaluation of the Calibreye System
Research Team
S
Shienal Patel
M
Michelle Tran
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here